GB/T 44586.1-2024 Active National standards

GB/T 44586.1-2024 In vitro diagnostic medical devices—Multiplex molecular testing for nucleic acids—Part 1:Terminology and general requirements for nucleic acid quality evaluation

Publish Date: 2024-09-29 Implement Date: 2025-04-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 84

Basic Information

Standard Code: GB/T 44586.1-2024

Standard Type: National standards

Standard Status: Active

is_force_gb: no

CCS Name: Medical devices

ICS Name: -

Publish Date: 2024-09-29

Implement Date: 2025-04-01

Pages: 28 pages

Scope

This document provides quality evaluation terminology and general requirements for nucleic acid as an analyte used in multiplex molecular detection. Multiplex molecular detection refers to a detection method that can simultaneously identify two or more nucleic acid target sequences. This document is applicable to all multiplex molecular detection methods used in in vitro diagnostic (IVD) medical devices and laboratory-developed tests (LDTs), and provides information on qualitative and quantitative detection of nucleic acid target sequences. The purpose of this document is to guide the quality control of detecting and/or qualitatively identifying human nucleic acid or microbial pathogen nucleic acid target sequences in human clinical specimens in multiplex molecular assays. This document is applicable to various molecular in vitro diagnostic tests in medical laboratories. It is also intended for use by laboratory customers, in vitro diagnostic developers, manufacturers, biobanks, institutions conducting biomedical research, commercial organizations, and regulatory authorities. This document is not applicable to metagenomics. Note: Test methods used internally in laboratories are referred to as "laboratory-developed methods", "LDTs", or "in-house tests".